Evidence map›Paper›PMID 26713055›Full record

ArticleJournal of Korean medical science2015

Persistence with Antihypertensive Medications in Uncomplicated Treatment-Naïve Patients: Effects of Initial Therapeutic Classes.

Young-Mi Ah, Ju-Yeun Lee, Yun-Jung Choi, Baegeum Kim, Kyung Hee Choi, Jisun Kong, Jung Mi Oh, Wan Gyoon Shin, Hae-Young Lee

Open access · goldAbstract read
In one paragraph

Article in Journal of Korean medical science, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.5field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 24 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Article
  4. Article
  5. Non-persistence to antihypertensive drug therapy in Lithuania.European journal of clinical pharmacology · 2022
    Article
  6. Article
  7. Beta blocker rebound phenomenon is important, but we do not know its definition, incidence or optimal prevention strategies.Hypertension research : official journal of the Japanese Society of Hypertension · 2020
    Review
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Young-Mi AhCollege of Pharmacy, Institute of Pharmaceutical Science and Technology, Hanyang University, Ansan, Korea.ORCID 0000-0003-1607-9828
Ju-Yeun LeeCollege of Pharmacy, Institute of Pharmaceutical Science and Technology, Hanyang University, Ansan, Korea.ORCID 0000-0002-2261-7330
Yun-Jung ChoiCollege of Pharmacy, Institute of Pharmaceutical Science and Technology, Hanyang University, Ansan, Korea.ORCID 0000-0002-1648-9264
Baegeum KimCollege of Pharmacy, Institute of Pharmaceutical Science and Technology, Hanyang University, Ansan, Korea.ORCID 0000-0002-0636-4548
Kyung Hee ChoiCollege of Pharmacy, Sunchon National University, Suncheon, Korea.ORCID 0000-0002-9532-1581
Jisun KongCollege of Pharmacy & Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul, Korea.ORCID 0000-0001-9061-8442
Jung Mi OhCollege of Pharmacy & Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul, Korea.ORCID 0000-0002-1836-1707
Wan Gyoon ShinCollege of Pharmacy & Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul, Korea.ORCID 0000-0001-9371-7040
Hae-Young LeeDepartment of Internal Medicine, Seoul National University Hospital, Seoul, Korea.ORCID 0000-0002-9521-4102
Hanyang University · KRSeoul National University · KRSeoul National University Hospital · KRSunchon National University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We aimed to assess one-year persistence with antihypertensive therapy (AHT) among newly treated uncomplicated hypertensive patients in Korea and to evaluate the effect of initial therapeutic classes on persistence. We retrospectively analyzed a random sample of 20% of newly treated uncomplicated hypertensive patients (n = 45,787) in 2012 from the National Health Insurance claims database. This group was classified into six cohorts based on initial AHT class. We then measured treatment persistence, allowing a prescription gap of 60 days. Adherence to AHT was assessed with the medication possession ratio. Calcium channel blockers (CCB, 43.7%) and angiotensin receptor blockers (ARB, 40.3%) were most commonly prescribed as initial monotherapy. Overall, 62.1% and 42.0% were persistent with any AHT and initial class at one year, respectively, and 64.2% were adherent to antihypertensive treatment. Compared with ARBs, the risk of AHT discontinuation was significantly increased with initial use of thiazide diuretics (hazard ratio [HR], 3.16; 95% confidence interval [CI] 2.96-3.74) and beta blockers (HR, 1.86; CI, 1.77-1.95) and was minimally increased with CCBs (HR, 1.12; CI, 1.08-1.15). In conclusion, persistence and adherence to AHT are suboptimal, but the differences are meaningful in persistence and adherence between initial AHT classes.

Indexed as

AdolescentAdrenergic beta-AntagonistsAdultAgedAged, 80 and overAngiotensin-Converting Enzyme InhibitorsAngiotensin Receptor AntagonistsAntihypertensive AgentsCalcium Channel BlockersCohort StudiesFemaleHumansHypertensionMaleMedication AdherenceMiddle AgedAdrenergic beta-AntagonistsAngiotensin-Converting Enzyme InhibitorsAngiotensin Receptor AntagonistsAntihypertensive AgentsCalcium Channel BlockersSodium Chloride Symporter InhibitorsAdherencePersistenceTherapeutic ClassUncomplicated Hypertension

Identifiers

PMID26713055
PMCPMC4689824
OpenAlexW2214577823

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.